IL17A and systemic lupus erythematosus: Here, we evaluated the IL-17 plasma levels among glucocorticoid-receiving and newly diagnosed SLE patients in comparison to healthy subjects to delineate the alterations of IL-17 in response to routine glucocorticoid therapies.